Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05848622 · ClinicalTrials.gov registry record · NA

Gait Rehabilitation to Treat FastOA

A NA study of Knee Osteoarthritis and Anterior Cruciate Ligament Injuries, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05848622 is a NA study of Knee Osteoarthritis and Anterior Cruciate Ligament Injuries that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 70 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05848622, a NA study of Knee Osteoarthritis and Anterior Cruciate Ligament Injuries, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.

Interventions

  • BEHAVIORAL Real-time gait biofeedback
  • BEHAVIORAL Sham real-time gait biofeedback

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-06-13
Est. Completion 2026-05
Phase NA

What the Registry Record Tells You About NCT05848622

The ClinicalTrials.gov registry entry for NCT05848622 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (77% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Real-time gait biofeedback is the first listed.

NCT05848622 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05848622 about?

NCT05848622 is a clinical study titled "Gait Rehabilitation to Treat FastOA". The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.

What is the current status of trial NCT05848622?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-06-13. Estimated completion is 2026-05.

What conditions does trial NCT05848622 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Anterior Cruciate Ligament Injuries, Osteo Arthritis Knee, Knee Injuries, Post-traumatic Osteoarthritis.

What interventions are being tested in trial NCT05848622?

The interventions under investigation include: Real-time gait biofeedback (BEHAVIORAL), Sham real-time gait biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT05848622?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05848622 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.